NCT00534274 - Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

April 30, 2012

Study Completion Date

September 30, 2013

Conditions

Breast Cancer

Interventions

OTHER

3'-deoxy-3'-[18F]fluorothymidine

Trial Locations (24)

13273

Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes, Marseille

13385

CHU de la Timone, Marseille

14076

Centre Regional Francois Baclesse, Caen

21079

Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon

29609

CHU Hopital A. Morvan, Brest

33075

Hopital Saint Andre, Bordeaux

33076

CHU de Bordeaux - Hopital Pellegrin, Bordeaux

33300

Polyclinique Bordeaux Nord Aquitaine, Bordeaux

34298

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier

37044

Centre Hospitalier Universitaire Bretonneau de Tours, Tours

44093

CHR Hotel Dieu, Nantes

44805

Centre Regional Rene Gauducheau, Nantes-Saint Herblain

49033

Centre Hospitalier Regional et Universitaire d'Angers, Angers

49036

Centre Paul Papin, Angers

59020

Centre Oscar Lambret, Lille

63011

Centre Jean Perrin, Clermont-Ferrand

64100

Centre Hospitalier de la Cote Basque, Bayonne

75475

Hopital Saint-Louis, Paris

75970

Hopital Tenon, Paris

76038

Centre Henri Becquerel, Rouen

86021

CHU Poitiers, Poitiers

92211

Centre Rene Huguenin, Saint-Cloud

06189

Centre Antoine Lacassagne, Nice

F-06202

Hopital de l'Archet CHU de Nice, Nice

All Listed Sponsors

lead

UNICANCER

OTHER